CSIMarket
 


Syros Pharmaceuticals Inc   (SYRS)
Other Ticker:  
 
 

Syros Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Syros Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 6.78, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Syros Pharmaceuticals Inc 's Average receivable collection period in the Sep 30 2023 quarter, has increased to 54 days, from 36 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 562 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 1230 to 3521.

What is Receivable Turnover Ratio?
What is Syros Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




SYRS Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change -3.32 % -54.86 % -45.97 % - -31.7 %
Receivable Turnover Ratio (TTM) 6.78 10.14 28.03 - -
SYRS's Total Ranking # 3521 # 1230 # 3003 # 2219 # 2840
Average receivable collection period 54 36 13 - -
Seq. Receivable Change -5.18 % -0.51 % - - -
Seq. Revenue Change 32.79 % -4.1 % - - -38 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 212
Healthcare Sector # 563
Overall Market # 3521

Receivable Turnover Ratio Statistics
High Average Low
0.15 0.07 0.01
(Jun 30 2022)   (Dec 31 2019)






Financial Statements
Syros Pharmaceuticals Inc 's Accounts Receivable $ 2 Millions Visit SYRS's Balance sheet
Syros Pharmaceuticals Inc 's Sales TTM $ 9 Millions Visit SYRS's Income Statement
Where are SYRS's Sales coming from? Visit SYRS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SYRS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for SYRS's Competitors
Receivables Turnover Ratio for SYRS's Suppliers
Accounts Receivables Turnover Ratio for SYRS's Customers

You may also want to know
SYRS's Growth Rates SYRS's Roa SYRS's Inventory Turnover Ratio SYRS's Dividend Comparisons
SYRS's Profitability Ratios SYRS's Roi SYRS's Asset Turnover Ratio SYRS's Dividend Growth
SYRS's Valuation Ratios SYRS's Roe SYRS's Financial Strength Ratios SYRS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Talkspace Inc   14.24 $ 137.071  Millions$ 9.623  Millions
Owens and Minor inc   14.22 $ 10,227.886  Millions$ 719.123  Millions
Ainos Inc   14.15 $ 1.140  Millions$ 0.081  Millions
Lifeloc Technologies Inc   14.00 $ 9.250  Millions$ 0.661  Millions
Corcept Therapeutics Inc  13.76 $ 450.026  Millions$ 32.698  Millions
Protalix Biotherapeutics inc   13.48 $ 63.625  Millions$ 4.719  Millions
Exact Sciences Corporation  13.39 $ 2,407.624  Millions$ 179.784  Millions
Icu Medical Inc  13.12 $ 2,247.910  Millions$ 171.300  Millions
Milestone Scientific Inc   13.11 $ 9.788  Millions$ 0.747  Millions
Dmk Pharmaceuticals Corporation  12.53 $ 3.525  Millions$ 0.281  Millions
Ideaya Biosciences Inc   12.46 $ 23.484  Millions$ 1.886  Millions
Nutriband Inc   12.45 $ 2.088  Millions$ 0.168  Millions
Precipio inc   12.45 $ 13.259  Millions$ 1.065  Millions
Nanovibronix Inc  12.43 $ 1.203  Millions$ 0.097  Millions
Revance Therapeutics Inc   12.38 $ 214.162  Millions$ 17.292  Millions
Equillium Inc   12.38 $ 42.632  Millions$ 3.444  Millions
Amylyx Pharmaceuticals Inc   12.30 $ 294.222  Millions$ 23.922  Millions
Caribou Biosciences Inc   12.19 $ 34.611  Millions$ 2.840  Millions
Teladoc Health Inc   12.17 $ 2,579.597  Millions$ 211.896  Millions
Reflect Scientific Inc   12.16 $ 1.370  Millions$ 0.113  Millions
International Stem Cell Corporation  12.16 $ 8.330  Millions$ 0.685  Millions
Merus N v   12.11 $ 45.674  Millions$ 3.773  Millions
Rockwell Medical inc   11.76 $ 79.550  Millions$ 6.763  Millions
Tg Therapeutics Inc   11.60 $ 189.773  Millions$ 16.357  Millions
Sunlink Health Systems Inc   11.57 $ 45.936  Millions$ 3.971  Millions
Surmodics Inc  11.49 $ 133.718  Millions$ 11.635  Millions
Travere Therapeutics Inc   11.46 $ 209.653  Millions$ 18.288  Millions
Zomedica Corp   11.36 $ 22.049  Millions$ 1.941  Millions
Integrated Biopharma Inc  11.32 $ 50.567  Millions$ 4.469  Millions
Eton Pharmaceuticals Inc   11.28 $ 31.887  Millions$ 2.826  Millions

Date modified: 2023-11-16T19:22:29+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com